![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2014/11/cancer-in-the-lungs-300x225.jpg)
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
Synthetic lethality results when mutant KRAS and EGFR proteins are co-expressed in human lung adenocarcinoma (LUAD) cells, revealing the biological basis for mutual exclusivity of